NRG raises $67M for mitochondrial drugs in neurodegeneration
Longevity Technology - 08-Sep-2025Funding backs trials of NRG5051, aiming to slow ALS and Parkinson’s by protecting neurons
Investments News
Early investors squeezed out in longevity biotech funding deals
Fight Aging! - 03-Sep-2025New funding terms cut early stakes by up to 100-to-1, threatening trust in longevity biotech
Novartis, Arrowhead sign $2b deal for Parkinson’s RNA therapy
Longevity Technology - 02-Sep-2025Experimental RNAi drug aims to silence alpha-synuclein and slow neurodegeneration
Minovia powers up mitochondrial medicine
Longevity Technology - 01-Sep-2025$350K grant fuels Minovia’s biomarker work, as early trials show promising patient gains
Debut raises $20M to pioneer AI-driven skin longevity ingredients
Longevity Technology - 28-Aug-2025Startup uses AI to explore billions of molecules for next-gen skincare innovation
Aubrai launches to fund longevity science with AI and blockchain
CoinDesk - 25-Aug-2025New DeSci platform uses tokens and AI to speed breakthroughs in ageing research
Genentech ends $2b cancer cell therapy pact with Adaptive
FierceBiotech - 18-Aug-2025Pharma giant retreats from costly cell therapy deals amid layoffs and R&D cuts
Leadership change ahead for Oxford Nanopore
Financial Times (FT) - 11-Aug-2025Gordon Sanghera to leave after 20 years as takeover interest grows in UK DNA sequencing firm
OneSkin raises $20M to boost skin longevity science
Longevity Technology - 08-Aug-2025New funding will help expand OneSkin’s reach and target ageing at the cellular level
Chai Discovery secures $70m to accelerate AI-driven protein design
Endpoints News - 06-Aug-2025Biotech startup’s valuation soars as it advances de novo protein generation with AI models.
Altos Labs appoints Joan Mannick as CMO to advance cellular rejuvenation
Endpoints News - 04-Aug-2025Her focus is on reversing disease through cellular rejuvenation
Sava raises $19m for next-gen glucose monitoring wearable
Longevity Technology - 31-Jul-2025With $19 million funding, the startup plans regulatory approvals and scaling
Immortal Dragons has launched with $40 million to support longevity research
Longevity Technology - 18-Jul-2025The fund bridges East-West collaboration and acts quickly using its own capital
Synchron challenges Neuralink with minimally invasive brain implant
PC MAG - 16-Jul-2025Stentrode lets users control devices with thoughts—implanted via blood vessels, not surgery
Mito Fund invests in Pretzel Therapeutics for mitochondrial disease therapies
Longevity Technology - 15-Jul-2025New investment fuels development of therapies targeting mtDNA-related energy disorders
AgeCurve’s new patent tracks cell aging using mutations
AgeCurve - 10-Jul-2025This can help doctors create better health tests and treatments
ScienceMachine raises 2.9m to accelerate biotech with AI
EU-Startups - 09-Jul-2025AI startup ScienceMachine speeds up drug discovery by automating complex biotech data analysis
Chugai, Gero ink $250m deal to target ageing
FierceBiotech - 07-Jul-2025Gero’s AI will uncover ageing targets; Chugai will develop antibody drugs to treat related diseases
China’s brain chips break new ground
Nature - 04-Jul-2025BCIs in China help paralysed users control devices, play games, and speak Mandarin in real time
Epigenica debuts scalable tech to track epigenetic ageing
Longevity Technology - 04-Jul-2025Epigenica launches scalable tech to decode epigenetic ageing and disease markers
DNA reborn: engineering life from scratch
BBC - 26-Jun-2025UK project aims to build human DNA from scratch, raising hopes for cures—and ethical concerns
Calico taps Mabwell’s anti-ageing antibody in $596m licensing deal
FierceBiotech - 26-Jun-2025Alphabet's Calico licenses IL-11 drug to target age-related diseases beyond China
Outsee raises 1.8m for AI genomics in drug discovery
Longevity Technology - 25-Jun-2025Nomaly uses AI to decode disease from genomes, enabling precision medicine with small datasets
Infinity Bio raises $8m to decode the antibody reactome
Longevity Technology - 24-Jun-2025Tech screens 1,000s of antibodies per assay; links chronic inflammation to faster ageing
Robot surgeons for eyes: ForSight aims to revolutionize cataract surgery
Forbes - 24-Jun-2025ForSight’s $125M boost powers eye-surgery robot tested in 300 pig-eye trials, human ops next
Display all news
